Evidence map›Paper›PMID 25072045›Full record

ReviewFrontiers in public health2014

Tick-borne pathogen - reversed and conventional discovery of disease.

Ellen Tijsse-Klasen, Marion P G Koopmans, Hein Sprong

Abstract readReview
In one paragraph

Review in Frontiers in public health, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed.

  1. Deep sequencing of 16mSystems · 2025
    Article
  2. Review
  3. Article
  4. Article
  5. The Eruptive Fevers at Sixes and Sevens.Open access emergency medicine : OAEM · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Circulation ofPathogens (Basel, Switzerland) · 2021
    Article
  15. Article
  16. Review
  17. Article
  18. Evaluation of Disease Causality of RarePathogens (Basel, Switzerland) · 2020
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ellen Tijsse-KlasenCentre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM) , Bilthoven , Netherlands.
Marion P G KoopmansCentre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM) , Bilthoven , Netherlands ; Erasmus Medical Center , Rotterdam , Netherlands.
Hein SprongCentre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM) , Bilthoven , Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Molecular methods have increased the number of known microorganisms associated with ticks significantly. Some of these newly identified microorganisms are readily linked to human disease while others are yet unknown to cause human disease. The face of tick-borne disease discovery has changed with more diseases now being discovered in a "reversed way," detecting disease cases only years after the tick-borne microorganism was first discovered. Compared to the conventional discovery of infectious diseases, reverse order discovery presents researchers with new challenges. Estimating public health risks of such agents is especially challenging, as case definitions and diagnostic procedures may initially be missing. We discuss the advantages and shortcomings of molecular methods, serology, and epidemiological studies that might be used to study some fundamental questions regarding newly identified tick-borne diseases. With increased tick-exposure and improved detection methods, more tick-borne microorganisms will be added to the list of pathogens causing disease in humans in the future.

Indexed as

Borrelia miyamotoiemerging diseasesIxodes ricinusNeoehrlichia mikurensispublic healthRickettsiatick-borne pathogens

Identifiers

PMID25072045
PMCPMC4083466

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.